ID22650A - Penggunaan penghambat-penghambat lipase usus lambung - Google Patents

Penggunaan penghambat-penghambat lipase usus lambung

Info

Publication number
ID22650A
ID22650A IDW990792A ID990792A ID22650A ID 22650 A ID22650 A ID 22650A ID W990792 A IDW990792 A ID W990792A ID 990792 A ID990792 A ID 990792A ID 22650 A ID22650 A ID 22650A
Authority
ID
Indonesia
Prior art keywords
lipase
lights
inhibitors
lipase lights
lights inhibitors
Prior art date
Application number
IDW990792A
Other languages
English (en)
Indonesian (id)
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID22650A publication Critical patent/ID22650A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IDW990792A 1997-02-05 1998-01-29 Penggunaan penghambat-penghambat lipase usus lambung ID22650A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05

Publications (1)

Publication Number Publication Date
ID22650A true ID22650A (id) 1999-12-02

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990792A ID22650A (id) 1997-02-05 1998-01-29 Penggunaan penghambat-penghambat lipase usus lambung

Country Status (28)

Country Link
US (1) US6147108A (ko)
EP (1) EP1017408B1 (ko)
JP (1) JP2001509173A (ko)
KR (1) KR100479968B1 (ko)
CN (1) CN1154505C (ko)
AR (1) AR011106A1 (ko)
AT (1) ATE292975T1 (ko)
AU (1) AU740375B2 (ko)
BR (1) BR9807655A (ko)
CA (1) CA2278854C (ko)
CZ (1) CZ295567B6 (ko)
DE (1) DE69829763T2 (ko)
DK (1) DK1017408T3 (ko)
ES (1) ES2239799T3 (ko)
HK (1) HK1025251A1 (ko)
HU (1) HU230834B1 (ko)
ID (1) ID22650A (ko)
IL (1) IL131007A0 (ko)
ME (1) ME00578A (ko)
NO (1) NO324452B1 (ko)
NZ (1) NZ336755A (ko)
PL (1) PL191222B1 (ko)
PT (1) PT1017408E (ko)
RU (1) RU2201272C2 (ko)
TR (1) TR199901853T2 (ko)
WO (1) WO1998034630A1 (ko)
YU (1) YU34199A (ko)
ZA (1) ZA98753B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7872095B2 (en) 2004-07-19 2011-01-18 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
ES2350798T3 (es) * 2007-09-12 2011-01-27 Mader S.R.L. Composiciones farmacéuticas para uso oral para tratar a pacientes afectados por la obesidad.
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
KR101234540B1 (ko) 2007-10-16 2013-02-19 바이오콘 리미티드 경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
US8768423B2 (en) 2008-03-04 2014-07-01 Glt Acquisition Corp. Multispot monitoring for use in optical coherence tomography
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
EP3429567B1 (en) * 2016-03-16 2024-01-10 The J. David Gladstone Institutes Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
PL334975A1 (en) 2000-03-27
ATE292975T1 (de) 2005-04-15
ZA98753B (en) 1998-08-05
DE69829763D1 (de) 2005-05-19
EP1017408A1 (en) 2000-07-12
CA2278854A1 (en) 1998-08-13
HUP0001014A3 (en) 2000-12-28
ME00578A (en) 2011-12-20
US6147108A (en) 2000-11-14
JP2001509173A (ja) 2001-07-10
BR9807655A (pt) 2000-02-15
CA2278854C (en) 2014-03-04
ES2239799T3 (es) 2005-10-01
DE69829763T2 (de) 2006-04-13
AR011106A1 (es) 2000-08-02
AU6616998A (en) 1998-08-26
TR199901853T2 (xx) 1999-12-21
HK1025251A1 (en) 2000-11-10
NO993717L (no) 1999-10-04
AU740375B2 (en) 2001-11-01
DK1017408T3 (da) 2005-08-01
NO993717D0 (no) 1999-07-30
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
KR100479968B1 (ko) 2005-03-30
CZ265199A3 (cs) 2000-02-16
WO1998034630A1 (en) 1998-08-13
KR20000070733A (ko) 2000-11-25
RU2201272C2 (ru) 2003-03-27
IL131007A0 (en) 2001-01-28
NO324452B1 (no) 2007-10-22
CN1246798A (zh) 2000-03-08
HUP0001014A2 (hu) 2000-08-28
CZ295567B6 (cs) 2005-08-17
PL191222B1 (pl) 2006-03-31
PT1017408E (pt) 2005-07-29
EP1017408B1 (en) 2005-04-13
HU230834B1 (hu) 2018-07-30
CN1154505C (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
ID22650A (id) Penggunaan penghambat-penghambat lipase usus lambung
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
NO995802L (no) Anvendelse av oljelegemer
ID24612A (id) Hidrogenolisis gliserol
ID19198A (id) Inhibitor metaloprotease heterosiklik
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
PT927183E (pt) Inibidores espirociclicos de metaloproteases
ID18416A (id) Inhibitor metaloprotease diheterosiklik
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
PT979240E (pt) Inibidores de serina-protease
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
ZA983065B (en) Inhibitors of protein farnesyltranferase
ID24270A (id) Penghilang sumbatan keratotik
ID23437A (id) Penghilang sumbatan keratotik
ID22379A (id) Hidrogenasi imina enamina
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
DE69828361D1 (de) Apoptose-inhibitor
DE69720957T2 (de) Ace-hemmer
ID17328A (id) Pemurnian epsilon-kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID21170A (id) Campuran kombinasi unit aerasi
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
UA1665S (uk) Комплект етикеток
UA2119S (uk) Комплект етикеток
UA1619S (uk) Комплект етикеток